The CYTO-PV: A Large-Scale Trial Testing the Intensity of CYTOreductive Therapy to Prevent Cardiovascular Events in Patients with Polycythemia Vera

Polycythemia vera (PV) is a chronic myeloproliferative disorder whose major morbidity and mortality are thrombohaemorragic events. Current guidelines advise maintaining hematocrit (HCT) level below 45% in males and 42% in females. Such targets lean on pathophysiological reasoning, while evidence fro...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Marchioli, Roberto, Finazzi, Guido, Specchia, Giorgina, Masciulli, Arianna, Mennitto, Maria Rosaria, Barbui, Tiziano
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2011
Assuntos:
Clinical Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3200258/
https://ncbi.nlm.nih.gov/pubmed/22084668
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2011/794240
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados